Clinical Evidence of Reduced Hemolysis with Butterfly Needles
, by Andrew Odgers, 14 min reading time
, by Andrew Odgers, 14 min reading time
Haemolysis is one of the leading causes of rejected blood samples and repeated venepuncture. A growing body of clinical research demonstrates that butterfly needles consistently produce lower haemolysis rates than straight needles, particularly in patients with difficult vein access. This guide summarises the evidence, explains the mechanism, and draws out the practical implications for procurement and clinical practice.
Haemolysis is the rupture of red blood cells, which releases haemoglobin and intracellular contents into the plasma. When it occurs during blood collection it is called pre-analytical haemolysis, meaning it happens before the sample reaches the laboratory analyser. The disrupted cells release potassium, lactate dehydrogenase, and other intracellular markers into the surrounding serum, altering the measured concentration of those analytes and making the results unreliable.
Haemolysis is detected visually as a pink or red tinge in the serum once the sample is centrifuged, or automatically by laboratory analysers that measure haemolysis index. Most laboratories have threshold values above which a sample is reported as haemolysed and rejected for some or all analytes.
A rejected haemolysed sample means the patient must be re-bled. In a busy phlebotomy service this has direct costs in staff time, consumables, and patient inconvenience. For inpatient or unwell patients, repeated venepuncture causes additional discomfort and can exhaust available vein access. For time-sensitive results such as potassium in acute kidney injury or troponin in chest pain, a haemolysed sample delays clinical decision-making.
Haemolysis rates of between 3 and 10 percent of all samples collected are commonly reported in hospital laboratories. Even at the lower end of this range, the cumulative cost across a large service is significant. Reducing haemolysis by even a few percentage points translates into fewer repeat collections, faster turnaround times, and lower overall cost per reportable result.
Multiple factors contribute to haemolysis during collection. Mechanical trauma to red cells caused by excessive force during aspiration, turbulent flow through a narrow lumen, a mismatch between needle gauge and the vacuum in the collection tube, and physical damage to the vein during needle insertion are all established causes. The choice of needle device is therefore one of several modifiable variables that affect haemolysis risk.
The most consistent evidence for butterfly needle superiority comes from studies conducted in emergency departments and on populations with difficult vein access. These settings produce the highest haemolysis rates overall, and it is here that the difference between needle types is most pronounced.
Multiple published studies comparing winged infusion sets to straight needle vacutainer systems in emergency or acute care settings have found haemolysis rates that are substantially lower in the butterfly needle groups. Absolute reductions in haemolysis rates of between 3 and 8 percentage points have been reported in several controlled comparisons, with the effect most pronounced in collections from hand veins and in patients described as having difficult or fragile vein access.
A frequently cited mechanism is the lower shear force applied to red cells during collection with a butterfly needle. The flexible tubing and lower insertion angle reduce the turbulence experienced by blood as it enters the needle, and the wing grip allows more controlled advancement of the needle through the vein wall, causing less physical disruption to the vessel.
Studies conducted on general ward patients show a smaller but still consistent reduction in haemolysis with butterfly needles compared to straight needles. The effect is less dramatic in this population because ward patients as a group tend to have better vein access than emergency department patients, and the relative advantage of the butterfly needle design is therefore less pronounced.
However, several ward-based studies have identified specific subpopulations where the difference is clinically significant. Elderly inpatients with age-related vein fragility, oncology patients whose veins have been compromised by previous treatment, and patients on long-term anticoagulation show substantially higher haemolysis rates with straight needles than with butterfly needles across multiple study populations.
In routine outpatient phlebotomy on healthy adults with good antecubital vein access, the evidence for a meaningful haemolysis difference between needle types is weaker. Several studies in this setting have found no statistically significant difference in haemolysis rates between the two device types when operator technique is controlled. This is consistent with the mechanistic understanding that the advantages of the butterfly needle are most relevant when vein access is difficult and the risk of mechanical trauma is higher.
The practical implication is that butterfly needles do not universally produce lower haemolysis in all patient populations. They provide the greatest benefit in the patients who are at highest risk of haemolysis in the first place.
Within both needle types, gauge is an independent variable affecting haemolysis risk. Narrower gauges produce more turbulent flow relative to the vacuum of the collection tube, increasing red cell shear. This effect is amplified when a narrow gauge needle is used with a standard adult vacutainer tube, whose vacuum is designed for faster collection rates than a 25 gauge needle can provide.
The solution is to match gauge to the collection tube size. When using a 25 gauge butterfly needle, collecting into smaller paediatric tubes reduces the effective vacuum and lowers haemolysis risk substantially. This paediatric tube technique is well-established practice in neonatal and difficult-access collections using butterfly needles.
The research points to clear, actionable conclusions for procurement decisions and daily technique.
Charles Medical supplies butterfly needles with integrated safety mechanisms across all clinical gauges. Order in unit or bulk quantities with next-day UK delivery.
For a full comparison of device types across all clinical scenarios, see Butterfly Needles vs Straight Needles: Pros, Cons and When to Use Each.
This article is part of our complete butterfly needle knowledge base, covering clinical use, gauge selection, technique, haemolysis reduction, cost analysis, patient guidance, and the full regulatory picture for UK procurement.
How Butterfly Needles Help in Reducing Complications in Blood Sample Collection covers haematoma, failed attempts, and patient discomfort alongside haemolysis. How Clinics Can Reduce Sample Rejection Rates by Using Butterfly Needles translates the evidence into an operational quality improvement framework. And Cost Analysis: Are Butterfly Needles Worth the Investment works through the financial case in detail.